Similar articles

• Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.

  Segars LW, Gales BJ. Segars LW, et al. Clin Pharm. 1992 Jun;11(6):514-28. Clin Pharm. 1992. PMID: 1600685 Review.
• [New treatments of hemorrhagic rectocolitis].

  Rambaud JC. Rambaud JC. Ann Gastroenterol Hepatol (Paris). 1988 Jun-Sep;24(4):173-7. Ann Gastroenterol Hepatol (Paris). 1988. PMID: 2901821 Review. French.
• Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.

  Barber GB, Lee DE, Antonioli DA, Peppercorn MA. Barber GB, et al. Am J Gastroenterol. 1985 Aug;80(8):612-4. Am J Gastroenterol. 1985. PMID: 2862789 Clinical Trial.
• A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.

  Kam L, Cohen H, Dooley C, Rubin P, Orchard J. Kam L, et al. Am J Gastroenterol. 1996 Jul;91(7):1338-42. Am J Gastroenterol. 1996. PMID: 8677990 Clinical Trial.
• [Current therapeutic possibilities in chronic inflammatory intestinal diseases].

  Schölmerich J. Schölmerich J. Praxis (Bern 1994). 1995 Jan 10;84(2):29-33. Praxis (Bern 1994). 1995. PMID: 7839043 German.